120 CDC HIV Awards Near Expiry, Threatening 8.7 Million Patients as State Department Tightens Control
Updated
Updated · CNN · Jul 10
120 CDC HIV Awards Near Expiry, Threatening 8.7 Million Patients as State Department Tightens Control
1 articles · Updated · CNN · Jul 10
Summary
September expirations for 120 CDC-funded HIV/AIDS awards could disrupt services for more than 8.7 million patients, with no clear replacement system in place before Oct. 1.
The lapse stems from a State Department overhaul of PEPFAR under its America First Global Health Strategy, shifting control from CDC and other agencies to bilateral country deals and a fee-for-service model.
Mozambique, Tanzania and South Africa are among the countries expected to be hit hardest; the awards support testing, clinical care, lab services and PrEP, and many programs have operated for 15 to 20 years.
State Department and HHS officials say CDC funding will increase and its technical role will be preserved, but a CDC official said some mechanisms are not yet set up and overall funding is expected to fall.
PEPFAR, launched in 2003 and credited with saving more than 26 million lives, is facing bipartisan pushback from 23 senators and former CDC directors who warn a rushed transition could weaken oversight and health outcomes.
With HIV prevention efforts collapsing, is the world's most successful health program creating a future pandemic?
Is life-saving AIDS relief being traded for Africa's mineral resources under a new US global health strategy?
Why is a proven system serving 8.7 million patients being dismantled without a ready replacement?
Global HIV Crisis 2026: Impacts of Expiring 120 CDC Awards and PEPFAR Restructuring on Prevention, Treatment, and Health Security
Overview
The report highlights a looming crisis as 120 CDC HIV/AIDS program awards are set to expire in September 2026, creating a serious risk of disruption to essential HIV prevention, care, and treatment services worldwide. This abrupt end leaves millions of people facing uncertainty and raises concerns about the continuity of care and the possible reversal of progress against HIV/AIDS. The situation is made worse by significant delays and the lack of replacement funding mechanisms, as the State Department’s new funding plans are not yet established. Without immediate solutions, hard-won gains in the fight against HIV/AIDS are at risk.